Interfacial Stress Regulates Plasticity and Drug Resistance at the Breast Cancer‐Host Interface
Advanced Science · 2025
DOI: 10.1002/advs.202509361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Bram G Soliman und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, University of New South Wales, Sydney, New South Wales, 2052, Australia. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Resistance, Neoplasm, Cell Plasticity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Health and Medical Research Council, National Cancer Institute of the National Institutes of Health.
Abstract (Originalsprache)
The confinement of breast cancer cells at the interface of the mammary gland lumen and its surrounding extracellular matrix is thought to be a key physical driver of cellular plasticity. The relationship between confinement‐induced solid stress and drug resistance is not well understood due to a scarcity of models that faithfully isolate the contribution of confinement on cancer cell behavior. Herein, drop‐on‐demand printing is used to uniquely replicate the spatial compartmentalization of the native cancer‐host interface: MCF‐7 breast cancer cells are dispensed within bioinert cup‐shaped alginate‐based hydrogels in high‐throughput to yield “confined” spheroids. Hydrogel confinement affects the emergence of CD44+‐CD133+ cells at the spheroid interface that drives a two‐fold increase in doxorubicin/tamoxifen resistance compared to control “unconfined” spheroids. Whilst the peripheral drug‐resistant phenotype is observed clinically, the model is unique in facilitating the emergence of this population in an in vitro setting. Pharmacological modulation of mechanotransduction proteins (YAP, myosin), abrogated the emergence of this peripheral phenotype, implicating mechanotransduction pathways as an effective way to target solid stress‐induced drug resistance. Together, this supports an “interfacial stress—stemness—drug resistance” relationship that sheds new light on the existing paradigm of spatial emergence of drug resistance in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry, University of New South Wales, Sydney, New South Wales, 2052, Australia.
- Australian Centre for NanoMedicine, University of New South Wales, Sydney, New South Wales, 2052, Australia.
- School of Materials Science and Engineering, University of New South Wales, Sydney, New South Wales, 2052, Australia.
ORCID-Profile: Bram G Soliman, Peilin Tian, Jiuyu Cui, Kristopher A Kilian, J Justin Gooding
Förderung
- NCI NIH HHS
- National Health and Medical Research Council
- National Cancer Institute of the National Institutes of Health
Zitieren
APA
Soliman, B. G., Tian, P., Cui, J., Kilian, K. A., & Gooding, J. J. (2025). Interfacial Stress Regulates Plasticity and Drug Resistance at the Breast Cancer‐Host Interface. Advanced Science. https://doi.org/10.1002/advs.202509361
Vancouver
Soliman BG, Tian P, Cui J, Kilian KA, Gooding JJ. Interfacial Stress Regulates Plasticity and Drug Resistance at the Breast Cancer‐Host Interface. Advanced Science. 2025. doi:10.1002/advs.202509361
BibTeX
@article{Soliman2025,
author = {Soliman, Bram G and Tian, Peilin and Cui, Jiuyu and Kilian, Kristopher A and Gooding, J Justin},
title = {Interfacial Stress Regulates Plasticity and Drug Resistance at the Breast Cancer‐Host Interface},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202509361}
}
EUVIMED